Prospective observational study on cytokine removal effect of continuous hemodiafiltration in COVID-19
Not Applicable
Recruiting
- Conditions
- Patients diagnosed with COVID-19 and undergoing continuous hemodiafiltration
- Registration Number
- JPRN-UMIN000040563
- Lead Sponsor
- Juntendo University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who the investigator determined to be inappropriate as subjects (Patients with severe anemia of Hb <6.0 g/dL, those with systolic blood pressure <70mmHg even after using sufficient amount of vasopressor)
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method